Financials
- Market Capitalization 152.3 M
- Employee 30
- Founded 2014
- CEO N/A
- Website www.novabridge.com
- Headquarter Cayman Islands
- FIGI BBG00QQ8DFK6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.29
ratio cours/chiffre d'affaires
876.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3671 | CDXS Codexis, Inc. - Common Stock | 1.41 USD | 0.00% | +0.71% | -2.76% | -42.91% | 154.40 M USD | ||
| 3674 | MOLN Molecular Partners AG - American Depositary Shares | 3.79 USD | -1.56% | -7.79% | -8.67% | +1.88% | 153.02 M USD | ||
| 3693 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.02 USD | -5.61% | -5.61% | -30.58% | -2.88% | 146.08 M USD | ||
| 3702 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.59 USD | -1.67% | -1.67% | -9.23% | +43.03% | 143.63 M USD |